UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 2.671

Sortiert nach

Activity of IPI-504, a Novel Heat-Shock Protein 90 Inhibitor, in Patients With Molecularly Defined Non–Small-Cell Lung Cancer

Journal of clinical oncology, 2010-11, Vol.28 (33), p.4953-4960

2010

Volltextzugriff (PDF)

Double-Blind, Randomized Trial of Docetaxel Plus Vandetanib Versus Docetaxel Plus Placebo in Platinum-Pretreated Metastatic Urothelial Cancer

Journal of clinical oncology, 2012-02, Vol.30 (5), p.507-512

2012

Volltextzugriff (PDF)

A whole-blood RNA transcript-based prognostic model in men with castration-resistant prostate cancer: a prospective study

The lancet oncology, 2012-11, Vol.13 (11), p.1105-1113

2012

Volltextzugriff (PDF)

Inherited Variation in the Androgen Pathway Is Associated With the Efficacy of Androgen-Deprivation Therapy in Men With Prostate Cancer

Journal of clinical oncology, 2008-02, Vol.26 (6), p.842-847

2008

Volltextzugriff (PDF)

Utility of a New Bolus-injectable Nanoparticle for Clinical Cancer Staging

Neoplasia (New York, N.Y.), 2007-12, Vol.9 (12), p.1160-1165

2007

Volltextzugriff (PDF)

Raoultella ornithinolytica and Klebsiella oxytoca pyogenic liver abscess presenting as chronic cough

IDCases, 2020-01, Vol.20, p.e00736, Article e00736

2020

Volltextzugriff (PDF)

Gene Therapy in Patients with Transfusion-Dependent β-Thalassemia

The New England journal of medicine, 2018-04, Vol.378 (16), p.1479-1493

2018

Volltextzugriff (PDF)

Neoadjuvant Dose-Dense Methotrexate, Vinblastine, Doxorubicin, and Cisplatin With Pegfilgrastim Support in Muscle-Invasive Urothelial Cancer: Pathologic, Radiologic, and Biomarker Correlates

Journal of clinical oncology, 2014-06, Vol.32 (18), p.1889-1894

2014

Volltextzugriff (PDF)

Phase I Study of the Hedgehog Pathway Inhibitor IPI-926 in Adult Patients with Solid Tumors

Clinical cancer research, 2013-05, Vol.19 (10), p.2766-2774

2013

Volltextzugriff (PDF)

A Randomized Phase II Trial of Short-Course Androgen Deprivation Therapy With or Without Bevacizumab for Patients With Recurrent Prostate Cancer After Definitive Local Therapy

Journal of clinical oncology, 2016-06, Vol.34 (16), p.1913-1920

2016

Volltextzugriff (PDF)

Multicenter Phase II Trial of the Heat Shock Protein 90 Inhibitor, Retaspimycin Hydrochloride (IPI-504), in Patients With Castration-resistant Prostate Cancer

Urology (Ridgewood, N.J.), 2011-09, Vol.78 (3), p.626-630

2011

Volltextzugriff (PDF)

Time to prostate‐specific antigen nadir independently predicts overall survival in patients who have metastatic hormone‐sensitive prostate cancer treated with androgen‐deprivation therapy

Cancer, 2009-03, Vol.115 (5), p.981-987

2009

Volltextzugriff (PDF)

A phase 2 study of carboplatin plus docetaxel in men with metastatic hormone‐refractory prostate cancer who are refractory to docetaxel

Cancer, 2008-02, Vol.112 (3), p.521-526

2008

Volltextzugriff (PDF)

Predictors of Prostate Cancer Tissue Acquisition by an Undirected Core Bone Marrow Biopsy in Metastatic Castration-Resistant Prostate Cancer—A Cancer and Leukemia Group B Study

Clinical cancer research, 2005-11, Vol.11 (22), p.8109-8113

2005

Volltextzugriff (PDF)

phase I study of oral panobinostat alone and in combination with docetaxel in patients with castration-resistant prostate cancer

Cancer chemotherapy and pharmacology, 2010-05, Vol.66 (1), p.181-189

2010

Volltextzugriff (PDF)

Phase 2 Study of Neoadjuvant Docetaxel Plus Bevacizumab in Patients With High-Risk Localized Prostate Cancer: A Prostate Cancer Clinical Trials Consortium Trial

Cancer, 2012-10, Vol.118 (19), p.4777-4784

2012

Volltextzugriff (PDF)

Efficacy of Androgen Deprivation Therapy (ADT) in Patients With Advanced Prostate Cancer : Association Between Gleason Score, Prostate-Specific Antigen Level, and Prior ADT Exposure With Duration of ADT Effect

Cancer, 2008-03, Vol.112 (6), p.1247-1253

2008

Volltextzugriff (PDF)

Prognostic Significance of Baseline Reverse Transcriptase-PCR for Prostate-Specific Antigen in Men with Hormone-Refractory Prostate Cancer Treated with Chemotherapy

Clinical cancer research, 2005-07, Vol.11 (14), p.5195-5198

2005

Volltextzugriff (PDF)

Osteoporosis in men treated with androgen deprivation therapy for prostate cancer

The Journal of urology, 2002-05, Vol.167 (5), p.1952

2002

Volltextzugriff (PDF)

Predicting outcomes in prostate cancer: how many more nomograms do we need?

Journal of clinical oncology, 2007-08, Vol.25 (24), p.3563-3564

2007

Volltextzugriff (PDF)

A pilot study of lymphotrophic nanoparticle-enhanced magnetic resonance imaging technique in early stage testicular cancer: A new method for noninvasive lymph node evaluation

Urology (Ridgewood, N.J.), 2005-11, Vol.66 (5), p.1066-1071

2005

Volltextzugriff (PDF)

Response to docetaxel/carboplatin‐based chemotherapy as first‐ and second‐line therapy in patients with metastatic hormone‐refractory prostate cancer

BJU international, 2008-02, Vol.101 (3), p.308-312

2008

Volltextzugriff (PDF)

Lymphotropic nanoparticle-enhanced magnetic resonance imaging (LNMRI) identifies occult lymph node metastases in prostate cancer patients prior to salvage radiation therapy

Clinical imaging, 2009-07, Vol.33 (4), p.301-305

2009

Volltextzugriff (PDF)

Germline CAG repeat length of the androgen receptor and time to progression in patients with prostate cancer treated with androgen deprivation therapy

BJU international, 2011-10, Vol.108 (7), p.1086-1091

2011

Volltextzugriff (PDF)

Gene Therapy in a Patient with Sickle Cell Disease

The New England journal of medicine, 2017-03, Vol.376 (9), p.848-855

2017

Volltextzugriff (PDF)

1 – 25 von 2.671

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(2.352)
Mit Volltextzugriff
(2.303)

Publikationsform

3 weitere anzeigen...

Weniger anzeigen...

Sprache

5 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(1.712)
Life Sciences & Biomedicine
(1.415)
Humans
(1.118)
Male
(649)
Female
(617)
Biological And Medical Sciences
(529)
Medical Sciences
(429)
Middle Aged
(398)
Animals
(344)
Adult
(330)
Aged
(316)
Cardiovascular System & Cardiology
(186)
Physical Sciences
(184)
Cardiac & Cardiovascular Systems
(169)
Oncology
(152)
Risk Factors
(148)
Adolescent
(146)
Surgery
(138)
Technology
(130)
General & Internal Medicine
(129)

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(17)

Menü

Weitere Dienste

Einstellungen

Activity of IPI-504, a Novel Heat-Shock Protein 90 Inhibitor, in Patients With Molecularly Defined Non–Small-Cell Lung Cancer

Double-Blind, Randomized Trial of Docetaxel Plus Vandetanib Versus Docetaxel Plus Placebo in Platinum-Pretreated Metastatic Urothelial Cancer

A whole-blood RNA transcript-based prognostic model in men with castration-resistant prostate cancer: a prospective study

Inherited Variation in the Androgen Pathway Is Associated With the Efficacy of Androgen-Deprivation Therapy in Men With Prostate Cancer

Utility of a New Bolus-injectable Nanoparticle for Clinical Cancer Staging

Raoultella ornithinolytica and Klebsiella oxytoca pyogenic liver abscess presenting as chronic cough

Gene Therapy in Patients with Transfusion-Dependent β-Thalassemia

Neoadjuvant Dose-Dense Methotrexate, Vinblastine, Doxorubicin, and Cisplatin With Pegfilgrastim Support in Muscle-Invasive Urothelial Cancer: Pathologic, Radiologic, and Biomarker Correlates

Phase I Study of the Hedgehog Pathway Inhibitor IPI-926 in Adult Patients with Solid Tumors

A Randomized Phase II Trial of Short-Course Androgen Deprivation Therapy With or Without Bevacizumab for Patients With Recurrent Prostate Cancer After Definitive Local Therapy

Multicenter Phase II Trial of the Heat Shock Protein 90 Inhibitor, Retaspimycin Hydrochloride (IPI-504), in Patients With Castration-resistant Prostate Cancer

Time to prostate‐specific antigen nadir independently predicts overall survival in patients who have metastatic hormone‐sensitive prostate cancer treated with androgen‐deprivation therapy

A phase 2 study of carboplatin plus docetaxel in men with metastatic hormone‐refractory prostate cancer who are refractory to docetaxel

Predictors of Prostate Cancer Tissue Acquisition by an Undirected Core Bone Marrow Biopsy in Metastatic Castration-Resistant Prostate Cancer—A Cancer and Leukemia Group B Study

phase I study of oral panobinostat alone and in combination with docetaxel in patients with castration-resistant prostate cancer

Phase 2 Study of Neoadjuvant Docetaxel Plus Bevacizumab in Patients With High-Risk Localized Prostate Cancer: A Prostate Cancer Clinical Trials Consortium Trial

Efficacy of Androgen Deprivation Therapy (ADT) in Patients With Advanced Prostate Cancer : Association Between Gleason Score, Prostate-Specific Antigen Level, and Prior ADT Exposure With Duration of ADT Effect

Prognostic Significance of Baseline Reverse Transcriptase-PCR for Prostate-Specific Antigen in Men with Hormone-Refractory Prostate Cancer Treated with Chemotherapy

Osteoporosis in men treated with androgen deprivation therapy for prostate cancer

Predicting outcomes in prostate cancer: how many more nomograms do we need?

A pilot study of lymphotrophic nanoparticle-enhanced magnetic resonance imaging technique in early stage testicular cancer: A new method for noninvasive lymph node evaluation

Response to docetaxel/carboplatin‐based chemotherapy as first‐ and second‐line therapy in patients with metastatic hormone‐refractory prostate cancer

Lymphotropic nanoparticle-enhanced magnetic resonance imaging (LNMRI) identifies occult lymph node metastases in prostate cancer patients prior to salvage radiation therapy

Germline CAG repeat length of the androgen receptor and time to progression in patients with prostate cancer treated with androgen deprivation therapy

Gene Therapy in a Patient with Sickle Cell Disease

Suchergebnisse filtern